Sue Hye Yoon

This inventor holds 6 USPTO granted patents, plus 1 CIPO patent and 2 EPO patents. Top assignees: Arimed Inc., Aribio Co., Ltd., Dong Wha Pharmaceutical Co. Ltd.. Active years: 2012-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sue Hye Yoon. Retrieved from https://idiyas.com/inventor/sue-hye-yoon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 6.8

ph-index = 2

Forward Citations = 10(Granted Patents)

Company Filing History:

Dong Wha Pharmaceutical Co. Ltd.

patents

Years Active: 2012-2017

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9751840 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2017-09-05),

2. 9452158 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2016-09-27),

3. 9150576 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1 acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2015-10-06),

4. 8952164 - R-7-(3-aminomethy-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydo-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2015-02-10),

5. 8664240 - R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and L-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial (2014-03-04),

6. 8324238 - Aspartate of 1-cyclopropyl-6-fluoro-7-(8-methoxyimino-2,6-diaza-spiro[3.4]oct-6-yl)-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid, method for preparing the same, and antimicrobial pharmaceutical composition comprising the same (2012-12-04),

Title: Innovations by Sue Hye Yoon

Introduction

Sue Hye Yoon is a prominent inventor based in Suwon-si, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of six patents to her name, her work has garnered attention for its innovative approaches to drug formulation.

Latest Patents

Among her latest patents are R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-acid and L-aspartic acid salt, along with the process for their preparation. These compounds are noted for their enhanced solubility and reduced toxicity compared to traditional antimicrobial agents. The formulations are designed to minimize side effects, making them suitable for both oral and injectable administration.

Career Highlights

Sue Hye Yoon has worked with notable companies such as Arimed Inc. and Aribio Co., Ltd. Her experience in these organizations has contributed to her expertise in pharmaceutical innovation. She has been instrumental in advancing research and development in her field.

Collaborations

Some of her coworkers include Dong Rack Choi and Jei Man Ryu. Their collaborative efforts have further enriched the research environment in which she operates.

Conclusion

Sue Hye Yoon's contributions to pharmaceutical innovations highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in antimicrobial therapies.

Profile summary based on public USPTO records.